It has been reported that SETD2 mutations were more frequently found in the hypoxic group of kidney tumors (65, 66), and the hypoxic group of HCC also had more patients with mutant SETD2 in our study (Figures 5B, C). The gene discussed is SETD2; the disease is kidney neoplasm.